Emerging trends in pharmaceutical design and drug manufacturing are shifting toward presenting the market with new ways to develop medications. Specialty medications continue to be a major area of pharmaceutical development and have become widely discussed in workers’ comp due to their significant costs. Although they represent approximately 1% of drug utilization, they account for nearly 7% of prescription drug costs and represent the fastest-growing segment of the U.S. pharmaceutical market. While specialty drug products are often associated with a hefty price tag, some can offer clinical advantages when deployed for the right patient at the right time, making careful oversight and patient selection imperative to achieving desired outcomes in this space. Watch the video blog to learn more.
More stories
Claims Journal
Article
A True Alternative to Opioids for Workers’ Comp? Questions Remain
Workers' Comp
Article
Proposed Utilization Review Amendments to California Workers' Compensation: What to Know
The California Division of Workers' Compensation (DWC) has proposed amendments to regulations relating to utilization review standards and related
Workers' Comp
Article
Get the Most Out of FairPay Flex: Expert Tips and Tricks
FairPay Flex, Enlyte
Workers' Comp
Article
Ask The Pharmacist: Buprenorphine’s Role in Workers’ Compensation Pain Management
What is the role of buprenorphine in pain management for workers’ compensation? Buprenorphine, a Schedule III controlled substance ap
Workers' Comp
Case Study
Overcoming Overpayment Risk With FairPay Flex
mitchell
News Release
Collision Claims Increased by More Than 30% While Average Severity Plateaued for Battery Electric Vehicles Last Year
SAN DIEGO, Calif.—Mitchell, an Enlyte company and leading technology and information provider for the